OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-based design, synthesis and antiproliferative action of new quinazoline-4-one/chalcone hybrids as EGFR inhibitors
Mohamed Hisham, Heba A. Hassan, Hesham A. M. Gomaa, et al.
Journal of Molecular Structure (2022) Vol. 1254, pp. 132422-132422
Closed Access | Times Cited: 33

Showing 26-50 of 33 citing articles:

Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAFV600E: Design, Synthesis, and Antiproliferative Activity
Lamya H. Al-Wahaibi, Mohamed Hisham, Hesham A. Abou‐Zied, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1522-1522
Open Access | Times Cited: 2

Synthesis and Antiproliferative Potential of Thiazole and 4-Thiazolidinone Containing Motifs as Dual Inhibitors of EGFR and BRAFV600E
Alaa A. Hassan, Nasr K. Mohamed, Ashraf A. Aly, et al.
Molecules (2023) Vol. 28, Iss. 24, pp. 7951-7951
Open Access | Times Cited: 2

Green synthesis of 2‐thioxo‐4‐quinazolinones from 2‐aminobenzamide and isothiocyanates
Ngoc Binh Vo, Le Thanh Hang Nguyen, Thi Yen Tran, et al.
Vietnam Journal of Chemistry (2024) Vol. 62, Iss. S1, pp. 147-152
Open Access

Investigating the activity of Quinazoline derivatives against T790 mutant EGFR receptors employing computer-aided drug design
Deepika Dinesh Adottu, Afanamol Mankulathil Shajahan, Shifa Ali Koolaparambil, et al.
Journal of Applied Pharmaceutical Science (2024)
Open Access

Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAFV600E inhibitors
Lamya H. Al-Wahaibi, Bahaa G. M. Youssif, Hesham A. Abou‐Zied, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2538-2552
Closed Access

Design, synthesis, and biological evaluation of novel quinoline-based EGFR/HER-2 dual-target inhibitors as potential anti-tumor agents
Lamya H. Al-Wahaibi, Essmat M. El‐Sheref, Hendawy N. Tawfeek, et al.
RSC Advances (2024) Vol. 14, Iss. 45, pp. 32978-32991
Open Access

Design, synthesis, and antiproliferative activity of new 1,2,3-triazole/quinazoline-4-one hybrids as dual EGFR/BRAFV600E inhibitors
Amira M. Mohamed, Ola M. F. Abou‐Ghadir, Yaser A. Mostafa, et al.
RSC Advances (2024) Vol. 14, Iss. 52, pp. 38403-38415
Open Access

Antitumor Activity and Multi-Target Mechanism of Phenolic Schiff Bases Bearing Methanesulfonamide Fragments: Cell Cycle Analysis and a Molecular Modeling Study
Alaa A.‐M. Abdel‐Aziz, Adel S. El‐Azab, Simone Brogi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13621-13621
Open Access

Previous Page - Page 2

Scroll to top